Skip to main content
Toggle navigation
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Red Recording
Sig Meeting
Like
Tweet
Print
Xiaoping Ning, MD
Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA
Poster(s):
(T 8) Fremanezumab for the Preventive Treatment of Episodic and Chronic Migraine in Children and Adolescents: Safety Outcomes From the SPACE Program
